Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 613-624 of 2,301
Drug study icon
CompletedNCT06058013

Effects of Oral NMRA-335140 Versus Placebo in people with Major Depressive Disorder

This study is completed in the United States, in Canada, in Brazil, .... It is testing Effects of Oral NMRA-335140 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Canada, Brazil, ...
Sponsor
Neumora Therapeutics, Inc.
Condition
Depression
Behavioral study icon
CompletedNCT03302611

study of Surf and Hike Therapy for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
United States Naval Medical Center, San Diego
Condition
Depression
Drug study icon
CompletedNCT04827901

XEN1101 for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
James Murrough
Condition
Depression
Drug study icon
Active Not RecruitingNCT03748446

Xenon Inhalation Therapy for Major Depressive Disorder and Bipolarity

This study is comparing Xenon with placebo for people with depression or Depression in bipolarity. Participants receive Xenon or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT03726658

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Syndeio Biosciences, Inc
Condition
Depression
Device study icon
CompletedNCT07258485

Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in people with Major Depressive Disorder (MDD)

This study is completed in the United States. It is testing Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 74 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed in the United States, in France, in Canada, .... It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT06514742

Aticaprant 10 mg for depression

This study was terminated in the United States, in Belgium, in Brazil, .... It is testing Aticaprant 10 mg for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, Belgium, Brazil, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT05455684

Aticaprant for depression

This study is completed in the United States, in Australia, in Belgium, .... It is testing aticaprant for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Australia, Belgium, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.